As Deadly Liver Cancer Rises, Collaborative, Targeted
Washington, D.C., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) launches its seventh annual #OctoberIs4Livers campaign to raise...
Washington, D.C., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) launches its seventh annual #OctoberIs4Livers campaign to raise...
1 IntroductionAs of 2020, liver cancer stands as the third leading cause of mortality worldwide, claiming the lives of 830,200...
HLB logo. On 16 May this year, the FDA issued a Complete Response Letter (CRL) requesting...
Research Impact is a series that pulls back the curtain of IU Research, showcasing the faculty creating, innovating and advancing...
Progression-free survival (PFS) in intermediate-stage hepatocellular carcinoma (HCC) improved by almost 5 months when a targeted agent and immunotherapy were...
Following abdominal surgery in 2024, surgeons removed some tissue from Catherine’s abdomen, which was later tested and found to be...